{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:02:41Z","timestamp":1787652161013,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00464-024-11169-z","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T19:02:21Z","timestamp":1723575741000},"page":"6070-6075","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Weighing your options\u2014intragastric balloon versus semaglutide"],"prefix":"10.1007","volume":"38","author":[{"given":"Kevin","family":"Choy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Abbitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Kovar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa S.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"McCallum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Saxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof J.","family":"Wikiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"issue":"1","key":"11169_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12916-018-1116-5","volume":"16","author":"AJ Tomiyama","year":"2018","unstructured":"Tomiyama AJ, Carr D, Granberg EM et al (2018) How and why weight stigma drives the obesity \u2018epidemic\u2019 and harms health. BMC Med 16(1):123","journal-title":"BMC Med"},{"key":"11169_CR2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.socscimed.2014.08.003","volume":"118","author":"AA Brewis","year":"2014","unstructured":"Brewis AA (2014) Stigma and the perpetuation of obesity. Soc Sci Med 118:152\u2013158","journal-title":"Soc Sci Med"},{"issue":"10","key":"11169_CR3","first-page":"868","volume":"69","author":"D S\u00e1nchez-Carracedo","year":"2022","unstructured":"S\u00e1nchez-Carracedo D (2022) Obesity stigma and its impact on health: a narrative review. Endocrinol Diabetes Nutr (Engl Ed) 69(10):868\u2013877","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"issue":"3","key":"11169_CR4","first-page":"354","volume":"27","author":"J Cawley","year":"2021","unstructured":"Cawley J, Biener A, Meyerhoefer C et al (2021) Direct medical costs of obesity in the United States and the most populous states. J Manag Care Spec Pharm 27(3):354\u2013366","journal-title":"J Manag Care Spec Pharm"},{"issue":"2","key":"11169_CR5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.hlpt.2017.02.002","volume":"6","author":"S Revels","year":"2017","unstructured":"Revels S, Kumar SAP, Ben-Assuli O (2017) Predicting obesity rate and obesity-related healthcare costs using data analytics. Health Policy Technol 6(2):198\u2013207","journal-title":"Health Policy Technol"},{"issue":"9","key":"11169_CR6","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11892-019-1191-9","volume":"19","author":"DL Wischik","year":"2019","unstructured":"Wischik DL, Magny-Normilus C, Whittemore R (2019) Risk factors of obesity in veterans of recent conflicts: need for diabetes prevention. Curr Diab Rep 19(9):70","journal-title":"Curr Diab Rep"},{"key":"11169_CR7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/1472-6963-13-511","volume":"13","author":"AC Del Re","year":"2013","unstructured":"Del Re AC, Maciejewski ML, Harris AH (2013) MOVE: weight management program across the Veterans Health Administration: patient- and facility-level predictors of utilization. BMC Health Serv Res 13:511","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"11169_CR8","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/osp4.622","volume":"8","author":"KM Robinson","year":"2022","unstructured":"Robinson KM, Vander Weg M, Laroche HH et al (2022) Obesity treatment initiation, retention, and outcomes in the Veterans Affairs MOVE! Program among rural and urban veterans. Obes Sci Pract 8(6):784\u2013793","journal-title":"Obes Sci Pract"},{"issue":"9","key":"11169_CR9","doi-asserted-by":"publisher","first-page":"7212","DOI":"10.1007\/s00464-023-10209-4","volume":"37","author":"D Abbitt","year":"2023","unstructured":"Abbitt D, Netsanet A, Kovar A et al (2023) Losing weight to achieve joint or hernia surgery: is the intragastric balloon the answer? Surg Endosc 37(9):7212\u20137217","journal-title":"Surg Endosc"},{"issue":"1","key":"11169_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1381\/09608920060674139","volume":"10","author":"B De Waele","year":"2000","unstructured":"De Waele B, Reynaert H, Urbain D, Willems G (2000) Intragastric balloons for preoperative weight reduction. Obes Surg 10(1):58\u201360","journal-title":"Obes Surg"},{"issue":"20","key":"11169_CR11","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1001\/jama.2023.19897","volume":"330","author":"A Elmaleh-Sachs","year":"2023","unstructured":"Elmaleh-Sachs A, Schwartz JL, Bramante CT, Nicklas JM, Gudzune KA, Jay M (2023) Obesity management in adults: a review. JAMA 330(20):2000\u20132015","journal-title":"JAMA"},{"key":"11169_CR12","first-page":"1","volume":"79","author":"C Allison","year":"2006","unstructured":"Allison C (2006) Intragastric balloons: a temporary treatment for obesity. Issues Emerg Health Technol 79:1\u20134","journal-title":"Issues Emerg Health Technol"},{"issue":"2","key":"11169_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.suc.2020.12.009","volume":"101","author":"MJ Klingler","year":"2021","unstructured":"Klingler MJ, Kroh M (2021) Endoscopic balloon therapy. Surg Clin North Am 101(2):355\u2013371","journal-title":"Surg Clin North Am"},{"issue":"Suppl 1","key":"11169_CR14","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.21037\/atm.2019.09.67","volume":"8","author":"KSC Gollisch","year":"2020","unstructured":"Gollisch KSC, Raddatz D (2020) Endoscopic intragastric balloon: a gimmick or a viable option for obesity? Ann Transl Med 8(Suppl 1):S8","journal-title":"Ann Transl Med"},{"issue":"14","key":"11169_CR15","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1001\/jama.2021.3224","volume":"325","author":"D Rubino","year":"2021","unstructured":"Rubino D, Abrahamsson N, Davies M et al (2021) Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA 325(14):1414\u20131425","journal-title":"JAMA"},{"issue":"2","key":"11169_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s13679-023-00502-7","volume":"12","author":"V Guglielmi","year":"2023","unstructured":"Guglielmi V, Bettini S, Sbraccia P et al (2023) Beyond weight loss: added benefits could guide the choice of anti-obesity medications. Curr Obes Rep 12(2):127\u2013146","journal-title":"Curr Obes Rep"},{"issue":"3","key":"11169_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.tcm.2021.12.008","volume":"33","author":"AM Chao","year":"2023","unstructured":"Chao AM, Tronieri JS, Amaro A, Wadden TA (2023) Semaglutide for the treatment of obesity. Trends Cardiovasc Med 33(3):159\u2013166","journal-title":"Trends Cardiovasc Med"},{"issue":"5","key":"11169_CR18","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3945\/ajcn.115.121178","volume":"103","author":"CM Peterson","year":"2016","unstructured":"Peterson CM, Thomas DM, Blackburn GL, Heymsfield SB (2016) Universal equation for estimating ideal body weight and body weight at any BMI. Am J Clin Nutr 103(5):1197\u20131203","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"11169_CR19","doi-asserted-by":"publisher","first-page":"e214182","DOI":"10.1001\/jamahealthforum.2021.4182","volume":"2","author":"LA Eberly","year":"2021","unstructured":"Eberly LA, Yang L, Essien UR et al (2021) Racial, ethnic, and socioeconomic inequities in glucagon-like peptide-1 receptor agonist Use among patients with diabetes in the US. JAMA Health Forum 2(12):e214182\u2013e214182","journal-title":"JAMA Health Forum"},{"issue":"3","key":"11169_CR20","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3390\/jpm12030454","volume":"12","author":"E Rentzeperi","year":"2022","unstructured":"Rentzeperi E, Pegiou S, Koufakis T, Grammatiki M, Kotsa K (2022) Sex Differences in response to treatment with glucagon-like peptide 1 receptor agonists: opportunities for a tailored approach to diabetes and obesity care. J Pers Med. 12(3):454","journal-title":"J Pers Med."},{"issue":"5","key":"11169_CR21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.5152\/tjg.2019.17877","volume":"30","author":"AE Haddad","year":"2019","unstructured":"Haddad AE, Rammal MO, Soweid A et al (2019) Intragastric balloon treatment of obesity: long-term results and patient satisfaction. Turk J Gastroenterol 30(5):461\u2013466","journal-title":"Turk J Gastroenterol"},{"issue":"3","key":"11169_CR22","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1007\/s11695-020-05117-8","volume":"31","author":"D Badurdeen","year":"2021","unstructured":"Badurdeen D, Hoff AC, Barrichello S et al (2021) Efficacy of liraglutide to prevent weight regain after retrieval of an adjustable intra-gastric balloon-a case-matched study. Obes Surg 31(3):1204\u20131213","journal-title":"Obes Surg"},{"issue":"8","key":"11169_CR23","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1089\/met.2018.0075","volume":"16","author":"M Camilleri","year":"2018","unstructured":"Camilleri M, Acosta A (2018) Combination therapies for obesity. Metab Syndr Relat Disord 16(8):390\u2013394","journal-title":"Metab Syndr Relat Disord"},{"issue":"8","key":"11169_CR24","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s12325-017-0562-3","volume":"34","author":"CM Tate","year":"2017","unstructured":"Tate CM, Geliebter A (2017) Intragastric balloon treatment for obesity: review of recent studies. Adv Ther 34(8):1859\u20131875","journal-title":"Adv Ther"},{"issue":"4","key":"11169_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1177\/87551225221092681","volume":"38","author":"A Fornes","year":"2022","unstructured":"Fornes A, Huff J, Pritchard RI, Godfrey M (2022) Once-weekly semaglutide for weight management: a clinical review. J Pharm Technol 38(4):239\u2013246","journal-title":"J Pharm Technol"},{"issue":"5","key":"11169_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.amepre.2011.06.047","volume":"41","author":"LC Kahwati","year":"2011","unstructured":"Kahwati LC, Lewis MA, Kane H et al (2011) Best practices in the Veterans Health Administration\u2019s MOVE! Weight management program. Am J Prev Med 41(5):457\u2013464","journal-title":"Am J Prev Med"},{"key":"11169_CR27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/1472-6963-11-248","volume":"11","author":"LJ Damschroder","year":"2011","unstructured":"Damschroder LJ, Goodrich DE, Robinson CH, Fletcher CE, Lowery JC (2011) A systematic exploration of differences in contextual factors related to implementing the MOVE! weight management program in VA: a mixed methods study. BMC Health Serv Res 11:248","journal-title":"BMC Health Serv Res"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-024-11169-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-024-11169-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-024-11169-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T04:03:43Z","timestamp":1728360223000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-024-11169-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["11169"],"URL":"https:\/\/doi.org\/10.1007\/s00464-024-11169-z","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,13]]},"assertion":[{"value":"19 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Edward Jones is a consultant for Boston Scientific. Drs. Kevin Choy, Danielle Abbitt, Alexandra Kovar, Teresa S. Jones, Molly McCallum, Elizabeth A. Thomas, David R. Saxon, MD, Krzysztof J. Wikiel report no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}